In vitro model of toxin therapy targeted against murine myeloid leukemia cells.
Tojo
A
A
Department of Hematology/Oncology, University of Tokyo, Japan.
Oshima
Y
Y
Ozawa
K
K
Niho
Y
Y
Asano
S
S
D000818:Animals; D005098:Exotoxins / Q000378:metabolism / Q000627:therapeutic use*; D016179:Granulocyte Colony-Stimulating Factor / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D007951:Leukemia, Myeloid / Q000628:therapy*; D051379:Mice; D011549:Pseudomonas; D016188:Receptors, Granulocyte Colony-Stimulating Factor / Q000378:metabolism; D011993:Recombinant Fusion Proteins / Q000378:metabolism / Q000627:therapeutic use*; D015398:Signal Transduction / Q000187:drug effects; D014407:Tumor Cells, Cultured / Q000187:drug effects
D005098:Exotoxins; D016188:Receptors, Granulocyte Colony-Stimulating Factor; D011993:Recombinant Fusion Proteins; D016179:Granulocyte Colony-Stimulating Factor